	流动资产		日
Acadia Pharmaceuticals	USD 1.22B	128.53M	2026-06
Adma Biologics	USD 528.2M	17.03M	2026-06
ALKERMES	USD 1.52B	164.26M	2026-06
Alterity Therapeutics Limited	AUD 37.91M	15.92M	2025-12
AstraZeneca	USD 27.97B	1.65B	2026-06
BioCryst Pharmaceuticals	USD 484.68M	111.06M	2026-06
Bristol-Myers Squibb	USD 28.58B	1.37B	2026-06
Cipla	INR 241.47B	7.71B	2026-03
Clal Biotechnology	ILS 14.69M	1.95M	2023-12
Compugen	USD 137.28M	10.74M	2026-03
CSL	USD 11.85B	1000K	2025-12
Eli Lilly	USD 64.67B	9.84B	2026-06
GlaxoSmithKline	GBP 17.56B	202M	2026-06
Grifols	EUR 5.96B	316.31M	2025-12
Halozyme Therapeutics	USD 933.02M	70.01M	2026-06
Ionis Pharmaceuticals	USD 2.49B	446.73M	2026-06
J&J	USD 59.77B	601M	2026-06
Merck	USD 36.68B	1.66B	2026-06
Minerva Neurosciences	USD 83.1M	70.08M	2025-12
Neurocrine Biosciences	USD 1.64B	798.6M	2026-06
Novartis	USD 27.35B	744M	2026-06
Novavax	USD 771.1M	79.72M	2026-06
Pfizer	USD 41.36B	1.46B	2026-06
Roche Holding	CHF 35.44B	3.29B	2026-06
Sanofi	EUR 31.52B	1.36B	2026-06
Takeda	JPY 3.15T	59.77B	2026-06
Vanda Pharmaceuticals	USD 347.26M	20.23M	2025-12